Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06853314 · ClinicalTrials.gov registry record · NA

An Effectiveness Trial of the PrEP for WINGS Study

A NA study, sponsored by Columbia University.

Recruiting
Registry status
NA
Development phase
307
Enrollment target

NCT06853314: Recruiting NA study, sponsored by Columbia University.

NCT06853314 is a NA study that is actively recruiting participants, run by Columbia University. The registered enrollment target is 307 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06853314, a NA study, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
NA
Development phase
307 participants
Enrollment target

Study Summary

(Effectiveness Aim 1) To test the comparative effectiveness of PreP for WINGS versus PrEP alone on primary outcomes of increasing PrEP initiation measured by self-report/medical records, recent adherence and longer-term adherence by self-report/medical records over the 6-month follow-up; and secondary outcomes of decreasing IPV, hazardous drinking, recidivism, and HIV risks. (Moderation Aim 2) To test if the effectiveness of WINGS+PrEP on study outcomes is moderated by key participant subgroups based on race/ethnicity, sexual orientation, age, education, incarceration history, IPV severity, substance use disorders (SUDs), digital access and literacy, housing stability, and medical mistrust.

Primary Outcome

Meeting with a PrEP provider to start PrEP once will meet the threshold for PrEP initiation.

Interventions

  • BEHAVIORAL PrEP for WINGS
  • BEHAVIORAL PrEP Decision Aid

Trial Details

FieldValue
Enrollment Target 307 participants
Start Date 2026-04-09
Est. Completion 2027-06-01
Phase NA
Columbia University

958 total trials

What NCT06853314 shows while recruiting

NCT06853314 is an interventional study that assigns participants to a tested intervention. The registered 307 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).

The record links to 0 conditions, and to 2 interventions - of which PrEP for WINGS is the first listed.

NCT06853314 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06853314 about?

NCT06853314 is a clinical study titled "An Effectiveness Trial of the PrEP for WINGS Study". (Effectiveness Aim 1) To test the comparative effectiveness of PreP for WINGS versus PrEP alone on primary outcomes of increasing PrEP initiation measured by self-report/medical records, recent adherence and longer-term adherence by self-report/medical records over the 6-month follow-up; and seconda...

What is the current status of trial NCT06853314?

This trial is currently recruiting. It is a NA study. The enrollment target is 307 participants. The study started on 2026-04-09. Estimated completion is 2027-06-01.

What interventions are being tested in trial NCT06853314?

The interventions under investigation include: PrEP for WINGS (BEHAVIORAL), PrEP Decision Aid (BEHAVIORAL).

Who is sponsoring clinical trial NCT06853314?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06853314's enrollment target sits among peer trials

307 324th of 2000 higher than 1,677 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05433142 · 307 participants · Phase 1

    Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

  • NCT04162938 · 308 participants · NA

    Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum

  • NCT04955795 · 308 participants · NA

    Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA

  • NCT06090539 · 308 participants · Phase 1

    A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06853314, the US trial registry maintained by the National Library of Medicine. NCT06853314 (mid enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.